{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:17:10Z","timestamp":1792016230385,"version":"4.4.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.clinph.2007.01.009","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T12:47:01Z","timestamp":1172839621000},"page":"1149-1154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Abnormal intracortical facilitation in early-stage Huntington\u2019s disease"],"prefix":"10.1016","volume":"118","author":[{"given":"R.","family":"Nardone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Lochner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Marth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Ausserer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Tezzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinph.2007.01.009_bib1","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(97)00363-7","article-title":"Intracortical inhibition and facilitation are abnormal in Huntington\u2019s disease: a paired magnetic stimulation study","volume":"228","author":"Abbruzzese","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clinph.2007.01.009_bib2","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJM199005033221807","article-title":"Abnormalities of striatal projection neurones and N-methyl-d-aspartate receptors in presymptomatic Huntington\u2019s disease","volume":"322","author":"Albin","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinph.2007.01.009_bib3","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","article-title":"Huntington\u2019s disease progression PET and clinical observations","volume":"122","author":"Andrews","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2007.01.009_bib4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/WNL.44.5.823","article-title":"Reduced basal ganglia volume associated with the gene for Huntington\u2019s disease in asymptomatic at-risk persons","volume":"44","author":"Aylward","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2007.01.009_bib5","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archneur.1996.00550120105023","article-title":"Basal ganglia volume and proximity to onset in presymptomatic Huntington disease","volume":"53","author":"Aylward","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinph.2007.01.009_bib6","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P","article-title":"Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington\u2019s disease","volume":"15","author":"Aylward","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinph.2007.01.009_bib7","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0306-4522(95)00164-E","article-title":"N-Methyl-d-aspartate transmission modulates GABAB-mediated inhibition of rat hippocampal pyramidal neurons in vitro","volume":"68","author":"Benardo","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.clinph.2007.01.009_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0006-8993(92)91195-K","article-title":"Regulation of excitatory amino acid release by N-methyl-d-aspartate receptors in rat striatum: in vivo microdialysis studies","volume":"585","author":"Bustos","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.clinph.2007.01.009_bib9","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington\u2019s disease","volume":"15","author":"Cepeda","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.clinph.2007.01.009_bib10","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1113\/jphysiol.1988.sp017390","article-title":"Two inhibitory postsynaptic potentials, and GABAA and GABAB receptor-mediated responses in neocortex of rat and cat","volume":"406","author":"Connors","year":"1988","journal-title":"J Physiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/263244a0","article-title":"Lesion of striatal neurones with kainic acid provides a model for Huntington\u2019s chorea","volume":"263","author":"Coyle","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.clinph.2007.01.009_bib12","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archneur.1997.00550230030012","article-title":"Early cognitive and motor symptoms in identified carriers for Huntington disease","volume":"54","author":"De Boo","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinph.2007.01.009_bib13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S1388-2457(99)00314-4","article-title":"Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex","volume":"111","author":"Di Lazzaro","year":"2000","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1113\/jphysiol.2002.030486","article-title":"Ketamine increases motor cortex excitability to transcranial magnetic stimulation","volume":"547","author":"Di Lazzaro","year":"2003","journal-title":"J Physiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib15","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1388-2457(01)00581-8","article-title":"New graphical method to measure silent periods evoked by transcranial magnetic stimulation","volume":"112","author":"Garvey","year":"2001","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib16","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/hmg\/2.6.635","article-title":"A PCR method for accurate assessment of trinucleotide repeat expansion in Huntington\u2019s disease","volume":"6","author":"Goldberg","year":"1993","journal-title":"Hum Mol Gent"},{"key":"10.1016\/j.clinph.2007.01.009_bib17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/ana.410280503","article-title":"A comparison of neurological, metabolic, structural, and genetic evaluations in person at risk for Huntington\u2019s disease","volume":"28","author":"Grafton","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinph.2007.01.009_bib18","doi-asserted-by":"crossref","unstructured":"HA\/WFN; International Huntington Association and the World Federation of neurology Research Group on Huntington\u2019s Chorea. Guidelines for the molecular genetics predictive test in Huntington\u2019s disease. J Med Genet 1994;31:555\u2013559.","DOI":"10.1136\/jmg.31.7.555"},{"key":"10.1016\/j.clinph.2007.01.009_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/35018000","article-title":"Transcranial magnetic stimulation and the human brain","volume":"406","author":"Hallett","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.clinph.2007.01.009_bib20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/jnnp.66.6.783","article-title":"Intracortical inhibition of the motor cortex is normal in chorea","volume":"66","author":"Hanajima","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.clinph.2007.01.009_bib21","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1212\/WNL.37.9.1441","article-title":"The combinate use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington\u2019s disease","volume":"37","author":"Hayden","year":"1987","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2007.01.009_bib22","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1152\/jn.1992.67.3.728","article-title":"Excitatory postsynaptic potentials recorded from regular-spiking cells in layers II\/III of rat sensorimotor cortex","volume":"67","author":"Hwa","year":"1992","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1113\/jphysiol.2002.030122","article-title":"Short-interval paired-pulse inhibition and facilitation of human motor cortex: the dimension of stimulus intensity","volume":"545","author":"Ilic","year":"2002","journal-title":"J Physiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib24","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/archneur.57.7.1040","article-title":"Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene","volume":"57","author":"Kirkwood","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinph.2007.01.009_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.1993.sp019912","article-title":"Corticocortical inhibition in human motor cortex","volume":"471","author":"Kujirai","year":"1993","journal-title":"J Physiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/brain\/awh058","article-title":"Regulation of proteins affecting NMDA receptor-induced excitotoxicity in a Huntington\u2019s mouse model","volume":"127","author":"Jarabek","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.clinph.2007.01.009_bib27","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.clinph.2006.04.012","article-title":"Motor cortex excitability studied with repetitive transcranial magnetic stimulation in patients with Huntington\u2019s disease","volume":"117","author":"Lorenzano","year":"2006","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib28","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/263517a0","article-title":"Duplication of biochemical changes in Huntington\u2019s chorea by intrastriatal injections of glutamic and kainic acids","volume":"263","author":"Mc Geer","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.clinph.2007.01.009_bib29","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S1388-2457(01)00599-5","article-title":"The prolonged cortical silent period in patients with Huntington\u2019s disease","volume":"112","author":"Modugno","year":"2001","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib30","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1523\/JNEUROSCI.17-08-02921.1997","article-title":"Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex","volume":"7","author":"Moghaddam","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.clinph.2007.01.009_bib31","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/mds.870090209","article-title":"Electromyographic silent period after transcranial brain stimulation in Huntington\u2019s disease","volume":"9","author":"Priori","year":"1994","journal-title":"Mov Disord"},{"issue":"I","key":"10.1016\/j.clinph.2007.01.009_bib32","first-page":"27","article-title":"Postexcitatory inhibition in Huntington\u2019s disease","volume":"7","author":"Roick","year":"1992","journal-title":"Mov Disord"},{"key":"10.1016\/j.clinph.2007.01.009_bib33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0013-4694(94)90029-9","article-title":"Non invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application: Report of IFCN committee","volume":"91","author":"Rossini","year":"1994","journal-title":"Electroenceph Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib34","series-title":"Plasticity in human nervous system. Investigations with transcanial magnetic stimulation","first-page":"26","article-title":"Techniques of transcranial magnetic stimulation","author":"Rothwell","year":"2003"},{"key":"10.1016\/j.clinph.2007.01.009_bib35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1469-7793.2001.0307l.x","article-title":"Interaction between two different inhibitory systems in the human motor cortex","volume":"530","author":"Sanger","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.29.1.1","article-title":"Huntington\u2019s disease: clinical care and evaluation","volume":"29","author":"Shoulson","year":"1979","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2007.01.009_bib37","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ana.410250308","article-title":"A controlled clinical trial of baclofen as protective therapy in early Huntington\u2019s disease","volume":"25","author":"Shoulson","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.clinph.2007.01.009_bib38","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s002210000532","article-title":"Riluzole suppresses motor cortex facilitation in correlation to its plasma level: a study using transcranial magnetic stimulation","volume":"135","author":"Schwenkreis","year":"2000","journal-title":"Exp Brain Res"},{"key":"10.1016\/j.clinph.2007.01.009_bib39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1001\/archneur.1996.00550060029011","article-title":"Motor cortex changes in presymptomatic Huntington disease gene carriers","volume":"53","author":"Siemers","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clinph.2007.01.009_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0924-980X(96)94645-7","article-title":"Postexcitatory inhibition after transcranial magnetic single and double brain stimulation in Huntington\u2019s disease","volume":"101","author":"Tegenthoff","year":"1996","journal-title":"Electroenceph Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib41","doi-asserted-by":"crossref","unstructured":"The Huntington\u2019s disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell 1993;72:971\u201383.","DOI":"10.1016\/0092-8674(93)90585-E"},{"key":"10.1016\/j.clinph.2007.01.009_bib42","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1469-7793.1999.0591t.x","article-title":"Differential effects on motocortical inhibition induced by blockade of GABA uptake in humans","volume":"517","author":"Werhahn","year":"1999","journal-title":"J Physiol"},{"key":"10.1016\/j.clinph.2007.01.009_bib43","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1126\/science.2841762","article-title":"NMDA receptor losses in putamen from patients with Huntington\u2019s disease","volume":"241","author":"Young","year":"1988","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.clinph.2007.01.009_bib44","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ana.410400306","article-title":"Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study","volume":"40","author":"Ziemann","year":"1996","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.clinph.2007.01.009_bib45","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1212\/WNL.51.5.1320","article-title":"Dextromethorphan decreases the excitability of the human motor cortex","volume":"51","author":"Ziemann","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2007.01.009_bib46","first-page":"189","article-title":"Assessment of motor cortex and descending motor pathways","volume":"vol. 1","author":"Ziemann","year":"2002"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245707000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245707000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:39:29Z","timestamp":1761388769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245707000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S1388245707000284"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2007.01.009","relation":{},"ISSN":["1388-2457"],"issn-type":[{"value":"1388-2457","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abnormal intracortical facilitation in early-stage Huntington\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2007.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}